This study will be a non-randomized pilot trial using Cyclophosphamide and Sirolimus for the treatment of metastatic differentiated thyroid cancer. Patients wi…

Metastatic Thyroid Cancer

~Estimated

~$10 – $6,250

University of Michigan Rogel Cancer CenterNCT03099356

Phase 2

Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: a Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)

This research is being done to determine the efficacy of selpercatinib to restore radioactive iodine (I-131 NaI) uptake and allow for I-131 treatment in people…

Thyroid CancerThyroid CarcinomaMetastatic Thyroid Cancer+3 more

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT05668962